Labile iron pool radiotracer [18F]TRX can predict sensitivity to iron-targeted tumor therapies Aug. 6, 2021 No Comments
89Zr-Immuno-PET using bispecific Abeta MAb as promising diagnostic strategy for Alzheimer's disease Aug. 5, 2021 No Comments
FDA clears INDs for targeted alpha therapy FPI-1966 and imaging agent FPI-1967 July 29, 2021 No Comments
Clarity initiates phase I/IIa theranostic trial of 64/67Cu SAR-bisPSMA in metastatic CRPC July 29, 2021 No Comments
Clarity recruits patients with prostate cancer to evaluate PET imaging with [64Cu]SAR-bisPSMA July 19, 2021 No Comments
New beta-amyloid PET imaging agent [18F]Flotaza shows promise in Alzheimer's disease brain July 7, 2021 No Comments
Washington University reports dosimetry data for brain PET radiotracer [11C]CS1P1 July 5, 2021 No Comments
RSS